Combining gp96-Ig vaccination and mTL1A-Ig fusion protein boosts anti-tumor immunity.

被引：0
|
作者：
Khan, Samia [1 ]
Schreiber, Taylor [1 ]
Deyev, Vadim [1 ]
Podack, Eckhard [1 ]
机构：
[1] Univ Miami, Miami, FL USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
165.10
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Boosting anti-tumor immunity by combining gp96-Ig vaccination and Ig-mTL1A fusion protein
    Khan, Samia
    Deyev, Vadim
    Podack, Eckhard
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [2] Tumor-Induced Suppression of CTL Expansion and Subjugation by gp96-Ig Vaccination
    Schreiber, Taylor H.
    Deyev, Vadirn V.
    Rosenblatt, Joseph D.
    Podack, Eckhard R.
    CANCER RESEARCH, 2009, 69 (05) : 2026 - 2033
  • [3] Gp96-Ig/Costimulator combination vaccine improves T cell priming, enhances immunity, memory, and tumor elimination
    Gonzalez, Louis
    Giffin, Louise
    Rose, Jason
    Fromm, George
    De Silva, Suresh
    Schreiber, Taylor
    Hutchins, Jeff
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Gp96-Ig/costimulator combination platform improves T cell priming and enhances immunity, memory, and tumor elimination
    Giffin, Louise
    Gonzalez, Louis
    Rose, Jason
    Hutchins, Jeff
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo
    Strbo, N
    Yamazaki, K
    Lee, K
    Rukavina, D
    Podack, ER
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 48 (04): : 220 - 225
  • [6] HLA A2 restricted HIV specific mucosal and systemic immunity induced with secreted heat shock protein gp96-Ig
    Strbo, Natasa
    Pahwa, Savita
    Kolber, Michael
    Fisher, Eva
    Franchini, Genoveffa
    Podack, Eckhard
    FASEB JOURNAL, 2008, 22
  • [7] Induction of Zika specific CD8 T cell responses in the placenta after heat shock protein gp96-Ig vaccination
    Strbo, Natasa
    Romero, Laura
    Fisher, Eva
    Garcia, Denisse
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [8] A novel TNFRSF25 agonist, PTX35, synergizes with Gp96-Ig/OX40L-Ig to enhance effector and memory anti-tumor CD8+T cell responses and delay tumor growth
    Tahiliani, Vikas
    Dillon, Patrick
    Miriyala, Jayalakshmi
    Trinh, Anh
    Jasuja, Rahul R.
    Hutchins, Jeff
    Seavey, Matthew M.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Generation of a novel, allogeneic cell-based, Gp96-Ig/OX40L cancer vaccine, improves anti-tumor immunity and long-term memory T-cell generation
    Tahiliani, Vikas
    Miriyala, Jayalakshmi
    Dillon, Patrick
    Rose, Jason
    Giffin, Louise
    Hutchins, Jeff
    Seavey, Matthew M.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Combined intratumoral electroporation and allogeneic vaccination of Gp96-Ig/Fc-OX40L stimulates CD8 T cell cross-priming to tumor specific neoantigens and enhanced anti-tumor response
    de Silva, Suresh
    Fromm, George
    Mukhopadhyay, Anandaroop
    Campbell, Jean
    Pierce, Robert
    Schreiber, Taylor
    CANCER RESEARCH, 2017, 77
1234